Home › Research › Health systems and care delivery
Post-discharge Follow-up of Standardized Management for Patients with Post-stroke Cognitive Impairment
Fei Li, Fengxia Hu, Yi Liang, Fen Liang, Huiqun Tan, Sisi Xing. Alternative therapies in health and medicine, 2024-11-01
Topic: Risk, prevention and care in population studies
Plain-language summary
At baseline, no significant difference (P > .05) existed between the groups in the scores: (1) for cognitive function on the MMSE or MoCA, (2) for the physiological, psychological, social, and environmental domains and the total score on the WHOQOL-BREF, or (3) for self-efficacy on the GSES scores. At 6 months postintervention, the intervention group's scores were significantly higher than those of the control group: (1) on the MMSE and MoCA (both P < .001), (2) on the four domains and total score on the WHOQOL-BREF (all P < .001), and (3) on the GSES (P < .001). At one month and six months postintervention, the intervention group's score for medication adherence on the MMAS-8 was significantly higher than those of the control group (both P < .001). Standardized management for patients with post-stroke cognitive impairment provided beneficial outcomes in improving their cognitive function, QoL, self-efficacy, and medication adherence, and the research team highly recommends it for wide application in clinical practice.
What this study adds
Evidence grade: High
This is a trial of 112 participants. This randomized controlled trial found that standardized management for patients with post-stroke cognitive impairment improved cognitive function, quality of life, self-efficacy, and medication adherence at 6 months. It does not test a treatment, cure, or prevention for Alzheimer's disease specifically.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Li, F., Hu, F., Liang, Y., Liang, F., Tan, H., & Xing, S. (2024). Post-discharge Follow-up of Standardized Management for Patients with Post-stroke Cognitive Impairment. Alternative therapies in health and medicine.
Vancouver
Li F, Hu F, Liang Y, Liang F, Tan H, Xing S. Post-discharge Follow-up of Standardized Management for Patients with Post-stroke Cognitive Impairment. Alternative therapies in health and medicine. 2024. PMID: 38430153.
BibTeX
@article{li2024-38430153,
author = {Li, Fei and Hu, Fengxia and Liang, Yi and Liang, Fen and Tan, Huiqun and Xing, Sisi},
title = {{Post-discharge Follow-up of Standardized Management for Patients with Post-stroke Cognitive Impairment}},
journal = {Alternative therapies in health and medicine},
year = {2024},
pmid = {38430153}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- At baseline, no significant difference (P > .05) existed between the groups in the scores: (1) for cognitive function on the MMSE or MoCA, (2) for the physiological, psychological, social, and environmental domains and the total score on the WHOQOL-BREF, or (3) for self-efficacy on the GSES scores.
- At 6 months postintervention, the intervention group's scores were significantly higher than those of the control group: (1) on the MMSE and MoCA (both P < .001), (2) on the four domains and total score on the WHOQOL-BREF (all P < .001), and (3) on the GSES (P < .001).
- At one month and six months postintervention, the intervention group's score for medication adherence on the MMAS-8 was significantly higher than those of the control group (both P < .001).
- Standardized management for patients with post-stroke cognitive impairment provided beneficial outcomes in improving their cognitive function, QoL, self-efficacy, and medication adherence, and the research team highly recommends it for wide application in clinical practice.
Why it matters
This randomized controlled trial found that standardized management for patients with post-stroke cognitive impairment improved cognitive function, quality of life, self-efficacy, and medication adherence at 6 months. It does not test a treatment, cure, or prevention for Alzheimer's disease specifically.
Study details
- Study designrandomized controlled trial
- Participants112
- Evidence strengthHigh
How this study scored 53/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for effect reported because the record does not state it. We have no data on journal's citation record, senior author's track record and institution's track record, so those were left out: it earned 47 of the 89 points we could judge it on, which is 53 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alternative therapies in health and medicine) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 11 / 12 | A randomized controlled trial |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 112 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 1 / 6 | Cited 0.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Sisi Xing holds only 3 work(s), too few to judge a track record — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 38430153) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 47 / 89 | Scored on 17 of 20 parts. We have no data for the rest, so they are left out: 47 of the 89 points we could judge it on is 53 out of 100. |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery from nearby years
Also tagged “mini-mental”
840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.